Detalhe da pesquisa
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med;
384(20): 1899-1909, 2021 05 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33951374
2.
Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).
Vaccine;
41(23): 3486-3492, 2023 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37149443
3.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV;
9(5): e309-e322, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35489376